Literature DB >> 14701710

Patients with active tuberculosis often have different strains in the same sputum specimen.

Robin M Warren1, Thomas C Victor, Elizabeth M Streicher, Madalene Richardson, Nulda Beyers, Nicolaas C Gey van Pittius, Paul D van Helden.   

Abstract

It is generally accepted that tuberculosis results from a single infection with a single Mycobacterium tuberculosis strain. Such infections are thought to confer protective immunity against exogenous reinfection. In this study, a novel polymerase chain reaction method was developed to specifically identify M. tuberculosis strains belonging to the Beijing and non-Beijing evolutionary lineages in sputum specimens collected from tuberculosis patients resident in an epidemiologic field site in Cape Town, South Africa. The sensitivity and specificity of the polymerase chain reaction-based strain classification method were 100% (95% confidence interval, 85-100%) when compared with DNA fingerprinting and spacer oligotyping (spoligotyping). Application of this method showed that 19% of all patients were simultaneously infected with Beijing and non-Beijing strains, and 57% of patients infected with a Beijing strain were also infected with a non-Beijing strain. Multiple infections were more frequent in retreatment cases (23%) as compared with new cases (17%), but were not associated with sex, age, or smear grading. These results suggest that multiple infections are frequent, implying high reinfection rates and the absence of efficient protective immunity conferred by the initial infection. This finding could influence our understanding of the epidemiology of disease in high-incidence regions and our understanding for vaccine development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14701710     DOI: 10.1164/rccm.200305-714OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  123 in total

1.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

2.  Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.

Authors:  Ted Cohen; Marc Lipsitch; Rochelle P Walensky; Megan Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

3.  Reconsidering global targets for tuberculosis control.

Authors:  B J Marais; P D van Helden
Journal:  Bull World Health Organ       Date:  2009-12       Impact factor: 9.408

4.  Mixed-strain Mycobacterium tuberculosis infections among patients dying in a hospital in KwaZulu-Natal, South Africa.

Authors:  Ted Cohen; Douglas Wilson; Kristina Wallengren; Elizabeth Y Samuel; Megan Murray
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

5.  Systematic survey of clonal complexity in tuberculosis at a populational level and detailed characterization of the isolates involved.

Authors:  Yurena Navarro; Marta Herranz; Laura Pérez-Lago; Miguel Martínez Lirola; Maria Jesús Ruiz-Serrano; Emilio Bouza; Darío García de Viedma
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

6.  Molecular epidemiology of HIV-associated tuberculosis in Dar es Salaam, Tanzania: strain predominance, clustering, and polyclonal disease.

Authors:  Lisa V Adams; Barry N Kreiswirth; Robert D Arbeit; Hanna Soini; Lillian Mtei; Mecky Matee; Muhammad Bakari; Timothy Lahey; Wendy Wieland-Alter; Elena Shashkina; Natalia Kurepina; Jeffrey R Driscoll; Kisali Pallangyo; C Robert Horsburgh; C Fordham von Reyn
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

7.  Rapid detection of Mycobacterium tuberculosis Beijing genotype strains by real-time PCR.

Authors:  Doris Hillemann; Rob Warren; Tanja Kubica; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

8.  Potential of rapid diagnosis for controlling drug-susceptible and drug-resistant tuberculosis in communities where Mycobacterium tuberculosis infections are highly prevalent.

Authors:  Pieter W Uys; Robin Warren; Paul D van Helden; Megan Murray; Thomas C Victor
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

9.  Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.

Authors:  Clare R Sander; Ansar A Pathan; Natalie E R Beveridge; Ian Poulton; Angela Minassian; Nicola Alder; Johan Van Wijgerden; Adrian V S Hill; Fergus V Gleeson; Robert J O Davies; Geoffrey Pasvol; Helen McShane
Journal:  Am J Respir Crit Care Med       Date:  2009-01-16       Impact factor: 21.405

Review 10.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.